oral semaglutide side effects A new class of GLP-1 that works differently than oral just got one step closer to FDA approval. Eli Lilly released new Phase 3 data on orforglipron. Swipe to learn Summary of practical guidance for

10.1146/annurev-pathol-012513-104649 166 OktayK

54 In an RCT for DJBL in patients with type 2 diabetes mellitus and obesity, 24% of the patients in the DJBL group achieved a 15% reduction in body weight compared to 4% in the control group at 12 months

It makes them feel understood and less isolated

Once released, GLP-1 helps the body to: Stimulate insulin release when blood glucose rises Reduce glucagon secretion, which helps prevent blood sugar spikes Slow gastric emptying, keeping food in the stomach for longer Increase feelings of fullness and reduce appetite These are important processes for metabolic health and energy balance

Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH